Projects per year
Personal profile
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Fingerprint
The Fingerprint is created by mining the titles and abstracts of the person's research outputs and projects/funding awards to create an index of weighted terms from discipline-specific thesauri.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Impact of early antiretroviral therapy on kidney disease outcomes
7/1/18 → 6/30/23
Project: Research project
-
-
Investigation of Causal Effects of Protein Biomarkers on Cardiovascular Disease in Persons With HIV
Reilly, C. S., Borges, Á. H., Baker, J. V., Safo, S. E., Sharma, S., Polizzotto, M. N., Pankow, J. S., Hu, X., Sherman, B. T., Babiker, A. G., Lundgren, J. D. & Lane, H. C., Apr 18 2023, In: The Journal of infectious diseases. 227, 8, p. 951-960 10 p.Research output: Contribution to journal › Article › peer-review
-
Cytomegalovirus viremia and risk of disease progression and death in HIV-positive patients starting antiretroviral therapy
Levi, L. I., Sharma, S., Schleiss, M. R., Furrer, H., Nixon, D. E., Blackstad, M., Hernandez-Alvarado, N., Dwyer, D. E., Borges, A. H., Lane, H. C., Lundgren, J., Neaton, J. D. & Molina, J. M., Jul 15 2022, In: AIDS. 36, 9, p. 1265-1272 8 p.Research output: Contribution to journal › Article › peer-review
5 Scopus citations -
Design and implementation of an international, multi-arm, multi-stage platform master protocol for trials of novel SARS-CoV-2 antiviral agents: Therapeutics for Inpatients with COVID-19 (TICO/ACTIV-3)
Murray, D. D., Babiker, A. G., Baker, J. V., Barkauskas, C. E., Brown, S. M., Chang, C. C., Davey, V. J., Gelijns, A. C., Ginde, A. A., Grund, B., Higgs, E., Hudson, F., Kan, V. L., Lane, H. C., Murray, T. A., Paredes, R., Parmar, M. K. B., Pett, S., Phillips, A. N., Polizzotto, M. N., & 8 others, Feb 2022, In: Clinical Trials. 19, 1, p. 52-61 10 p.Research output: Contribution to journal › Article › peer-review
8 Scopus citations -
Responses to a Neutralizing Monoclonal Antibody for Hospitalized Patients With COVID-19 According to Baseline Antibody and Antigen Levels: A Randomized Controlled Trial
Lundgren, J. D., Grund, B., Barkauskas, C. E., Holland, T. L., Gottlieb, R. L., Sandkovskyc, U., Brownc, S. M., Knowlton, K. U., Self, W. H., Files, D. C., Jain, M. K., Benfield, T., Bowdishc, M. E., Leshnower, B. G., Bakerc, J. V., Jensen, J. U., Gardner, E. M., Ginde, A. A., Harris, E. S., Johansen, I. S., & 33 others, Feb 1 2022, In: Annals of internal medicine. 175, 2, p. 234-243 10 p.Research output: Contribution to journal › Article › peer-review
36 Scopus citations -
Tixagevimab–cilgavimab for treatment of patients hospitalised with COVID-19: a randomised, double-blind, phase 3 trial
ACTIV-3–Therapeutics for Inpatients with COVID-19 (TICO) Study Group, Oct 2022, In: The Lancet Respiratory Medicine. 10, 10, p. 972-984 13 p.Research output: Contribution to journal › Article › peer-review
Open Access29 Scopus citations